Koyfin Home > Directory > Health Care > Abeona Therapeutics > EBITDA

Abeona Therapeutics EBITDA Chart (ABEO)

Abeona Therapeutics annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Abeona Therapeutics EBITDA for the quarter ending June 06, 2020 was $-12m a -34.09% increase of 4m year over year
  • Abeona Therapeutics EBITDA for the last 12 months ending June 06, 2020 was $-55m a -30.49% increase of 17m year over year
  • Abeona Therapeutics Annual EBITDA for 2019 was $-69m a 19.44% decrease of -13m from 2018
  • Abeona Therapeutics Annual EBITDA for 2018 was $-56m a 51.45% decrease of -29m from 2017
  • Abeona Therapeutics Annual EBITDA for 2017 was $-27m a 14.91% decrease of -4m from 2016
Other Income Statement Metrics:
  • Abeona Therapeutics Net Income for the quarter ending September 09, 2018 was $-16m a 48.54% decrease of -8m year over year
  • Abeona Therapeutics Total Revenue for the quarter ending September 09, 2018 was $2m a 87.42% increase of 1m year over year
View Chart On Koyfin

Quarterly ABEO EBITDA Data

06/2020$-12m
03/2020$-13m
12/2019$-14m
09/2019$-16m
06/2019$-22m
03/2019$-17m
12/2018$-17m
09/2018$-16m
06/2018$-12m
03/2018$-11m

Annual ABEO EBITDA Data

2019$-69m
2018$-56m
2017$-27m
2016$-23m
2015$-18m
2014$-3m
2013$-4m
2012$-4m
2011$-8m
2010$-8m